Christopher Rovaldi - Chief Operating Officer at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
KROS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Rovaldi since 4/23/2024

Holdings reported by Christopher Rovaldi for Keros Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 60K $2.64M $44.01 Feb 18, 2025 Direct

Transactions reported by Christopher Rovaldi for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.